ClinicalTrials.Veeva

Menu

Does the Ingestion of Mycoprotein Elicit an Optimal Anabolic Response in Resting and Exercised Skeletal Muscle? (ARM)

U

University of Exeter

Status

Completed

Conditions

Healthy

Treatments

Other: Mycoprotein beverage
Other: Milk protein beverage

Study type

Interventional

Funder types

Other

Identifiers

NCT02984345
660065600

Details and patient eligibility

About

The present study will seek to quantify the muscle protein synthetic response to mycoprotein feeding, comparing it to milk protein as a gold standard and heavily researched positive control

Enrollment

20 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

• BMI between 18 and 30 -

Exclusion criteria

  • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
  • Any diagnosed cardiovascular disease or hypertension.
  • Elevated blood pressure at the time of screening (e.g. blood pressure of ≥140/90mmHg).
  • Chronic use of any prescribed or over the counter pharmaceuticals.
  • A personal or family history of epilepsy, seizures or schizophrenia.
  • Anyone with previous motor disorders.
  • An allergy to mycoprotein / Quorn, penicillin, or milk.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups, including a placebo group

Mycoprotein beverage
Active Comparator group
Treatment:
Other: Mycoprotein beverage
Milk protein beverage
Placebo Comparator group
Treatment:
Other: Milk protein beverage

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems